BSG Report: Achieving a Winning Business Case to Improve Outcomes in Gastroenterology & Hepatology Services
Click here to view the action plan recently published by the British Society of Gastroenterology (BSG) following a series of workshops looking at best practices to achieve a winning business case for Hepatology and Gastroenterology service improvement in the NHS.
English Parliamentary Constituency Liver Disease Profiles
As part of its mission to increase awareness of liver disease amongst parliamentarians and policy makers the Lancet Commission for Liver Disease has been working with Incisive Health to produce profiles of the burden of liver disease across England. The profiles have been customised to show data including Years of Life Lost, Mortality Rate and Hospital Admissions that is specific to each of the 533 parliamentary constituencies in England.
The details of your MP and name of their parliamentary constituency in your place of residence or work can be located here: http://www.parliament.uk/mps-lords-and-offices/mps If you are meeting or writing to your MP please include a copy of your profile for their information and to help make them aware of the liver disease epidemic in England.
Hepatitis B Toolkit for at risk babies
This toolkit has been written by experts in the field, including the British Liver Trust, who have experience in the development of care pathways for the neonatal hepatitis B vaccination programme and delivery of the service at a local level.
It supports the Department of Health (DH) 2011 Hepatitis B antenatal screening and immunisation programme guidance by offering practical detailed solutions to three vaccine delivery models.
Please note that this toolkit has been sponsored by Sanofi Pasteur MSD Limited UK, who had editorial input to the content.
HEPscreen Toolkit for Viral Hepatitis Screening in EU Migrants
A European project to assess, describe and communicate to public health professionals the tools and conditions necessary for implementing successful screening programmes for hepatitis C among migrants in the European Union. For full information and to access the tool kit click here.
Hepatitis C in the South Asian Community: A Best Practice Casebook
This casebook, produced by Bristol Myers Squibb with input from the British Liver Trust and Hepatitis C Trust aims to support commissioners to deliver Hepatitis C services, which focus on the South Asian Community, by identifying a series of best practice case studies spanning different aspects of the patient pathway including: establishing prevalence, working with the local community, raising awareness, engaging General Practitioners (GPs) and delivering diagnosis and testing services. View the Casebook.
NICE guidance on Hepatitis B and C testing
NICE published guidelines in December 2012 on ways to promote and offer testing for Hepatitis B and C for people at increased risk of infection.
The guidance is for commissioners and providers of public health services, hepatitis testing and treatment services and laboratory services for hepatitis B and C testing. It is also for local organisations providing services for children and adults at increased risk of hepatitis B and C infection, including those in the NHS, local authorities, prisons, immigration removal centres and drugs services, and for voluntary sector and community organisations working with people at increased risk.
The guidance may also be of interest to groups at increased risk of viral hepatitis, for example, migrant populations from countries with an intermediate or high prevalence of hepatitis B or C infection or people who inject drugs and their families.
Please visit the following website for more information and to download the full guidance: http://guidance.nice.org.uk/PH43
NICE Guidance on Assessment and Management of Cirrhosis and NAFLD
NICE published two new new guidelines in July 2016 on the assessment and management of Cirrhosis and Non-Alcohol Related Fatty Liver Disease (NAFLD) in liver patients. Details are as follows:
Cirrhosis in over 16 year olds:
This guideline covers assessing and managing suspected or confirmed Cirrhosis in those aged 16 years or older. It aims to improve how cirrhosis is identified and diagnosed. It recommends tools to assess the severity of cirrhosis and gives advice on monitoring people with cirrhosis to detect and manage complications early, and referral criteria for tertiary care. See the full guidance by clicking here and read information for the public here.
Non-Alcohol Related Fatty Liver Disease (NAFLD)
This guideline covers how to identify the adults, young people and children with Non-Alcohol Related Fatty Liver Disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced liver fibrosis. See the full guidance by clicking here and read information for the public here.
NICE Quality Standards Topic Library
The new public health library of topics for quality standard and associated guideline development has now been launched. To view the quality standards that have been referred to NICE for development across healthcare, social care and public health please visit: www.nice.org.uk/Quality-standards-topic-library
Primary Care guide to chronic liver disease
NHS Liver Care has worked with a number of partners to publish a special liver issue of the British Journal of Primary Care Nursing and Primary Care Cardiovascular Journal. Primary care has a central role to play in improving the prevention and early detection of chronic liver disease. A lot of liver disease is preventable, and its progression can be slowed if diagnosed early enough.
This publication is designed to help primary care professionals face the challenges of liver disease. This special issue can be accessed online here.
SIRT UK Network (SUN)
SIRT, also called “Radioembolisation”, is a method of treating malignant liver tumours, whether those tumours originate from the liver itself, or have spread to the liver from elsewhere in the body (e.g. bowel cancer). The SIRT UK network is a web-based network of motivated clinicians and scientists (clinical oncology, interventional radiology, imaging, nuclear medicine and surgery) to share best practice, clinical experiences, patient information and to organise SIRT masterclasses and workshops.
For more information please visit the website at www.sirt.org.uk
The Transplantation Society – Living Donors Survey for Professionals
The Transplantation Society Ethics Committee is undertaking a survey of professionals working in donation and transplantation regarding psychosocial evaluation of living organ donors. We are also collecting guidelines or policy documents concerning donor evaluation. The data collected will be used by the Committee to develop resources for transplant professionals working with living donors in a variety of sociocultural contexts. To find out more or take the survey please visit: www.tts.org/education/the-transplantation-society-ethics-committee-survey
Understand Hep B and C
A film resource website launched by Maslaha to raise awareness and understanding of Hepatitis B and C amongst the Pakistani community. The website contains short films in both English and Urdu combining medical and cultural guidance to understand, prevent and get tested for hepatitis B & C. To view the website and resources click here
Viral Hepatitis Community
The Viral Hepatitis Community is a website to disseminate knowledge on hepatitis B, hepatitis C and also hepatocellular carcinoma for all hepatologists. It aims to gather all the international news on these pathologies, Viral Hepatitis Community facilitates an equal and regular access to optimal hepatitis information. Please click here for more information.
WHO Guidelines for Chronic Hepatitis B infection
World Health Organisation guidelines for the prevention, care and treatment of persons with chronic Hepatitis B infection. Click here to read the guidelines.
NIHR Funding Opportunities
The National Institute for Health Research (NIHR) is advertising two liver related research funding opportunities for the Health Technology Assessment (HTA) programme as follows:
16/75 – Zoledronic acid to reduce fractures in patients with alcoholic liver disease
16/99 – Primary prevention of variceal bleeding in patients with liver cirrhosis
To find out more about these topic or other NIHR advertised topics please see their funding opportunities webpage.